Skip to main content
Equibles

Philip Lemons

Board Member

Liminatus Pharma, Inc. (LIMN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Liminatus Pharma, Inc. publishes a filing, an earnings call transcript or a press release.

Get LIMN alerts

About Philip Lemons

Philip Lemons is recorded as Board Member at Liminatus Pharma, Inc. (LIMN). The newest filing on record that lists Philip Lemons as Board Member at Liminatus Pharma, Inc. (LIMN) is dated July 13, 2026. Liminatus Pharma, Inc. reported in an 8-K filed July 11, 2025 that Philip Lemons was appointed director, effective July 10, 2025. Liminatus Pharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Liminatus Pharma, Inc. includes Chris Kim (CEO and Board Member), Scott Dam (CFO), Beom K. Choi (CTO) and 4 others.

“On July 10, 2025, the board of directors (the "Board") of Liminatus Pharma, Inc. (the "Company") increased the size of the Board to six (6) members and appointed Philip Lemons and Richard Baek as directors of the Company, effective immediately.”
Liminatus Pharma, Inc. Form 8-K, filed July 11, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Liminatus Pharma, Inc.

Recent activity